Get the Stockscreener App
2.30
0.88%
0.02
Pre-market:
2.42
0.12
+5.22%
Codexis Inc stock is traded at $2.30, with a volume of 331.09K.
It is up +0.88% in the last 24 hours and down -25.08% over the past month.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
See More
Previous Close:
$2.28
Open:
$2.28
24h Volume:
331.09K
Relative Volume:
0.38
Market Cap:
$174.79M
Revenue:
$70.14M
Net Income/Loss:
$-76.24M
P/E Ratio:
-2.0721
EPS:
-1.11
Net Cash Flow:
$-57.06M
1W Performance:
+9.00%
1M Performance:
-25.08%
6M Performance:
-23.08%
1Y Performance:
-17.86%
1-Day Range:
$2.22
$2.33
1-Week Range:
$2.10
$2.43
52-Week Range:
$1.90
$6.08
Codexis Inc Stock (CDXS) Company Profile
Name
Codexis Inc
Sector
Industry
Phone
650-421-8100
Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.30 | 174.79M | 70.14M | -76.24M | -57.06M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.47 | 125.74B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
599.76 | 61.57B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
600.51 | 36.40B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.61 | 30.36B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
256.16 | 24.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | The Benchmark Company | Buy → Hold |
| Jun-03-24 | Resumed | Jefferies | Buy |
| May-30-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-29-24 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-07-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-07-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| May-09-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-31-22 | Resumed | Piper Sandler | Overweight |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Mar-01-21 | Initiated | Stifel | Buy |
| Feb-26-21 | Reiterated | H.C. Wainwright | Buy |
| Mar-10-20 | Initiated | The Benchmark Company | Buy |
| Jan-17-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| May-16-18 | Initiated | Stephens | Overweight |
| Oct-13-17 | Reiterated | H.C. Wainwright | Buy |
| May-31-17 | Initiated | Jefferies | Buy |
| Jan-26-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Jan-04-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-06-16 | Initiated | H.C. Wainwright | Buy |
View All
Codexis Inc Stock (CDXS) Latest News
Codexis, Inc. (NASDAQ:CDXS) Holdings Decreased by Russell Investments Group Ltd. - Defense World
Codexis Inc [CDXS] Shares Rise 2.24 % on Wednesday - knoxdaily.com
Codexis Inc (CDXS) stock analysis: A comprehensive overview - uspostnews.com
Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy? - Nasdaq
Geode Capital Management LLC Boosts Stock Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis (CDXS) Projected to Post Earnings on Thursday - Defense World
Quarterly Snapshot: Quick and Current Ratios for Codexis Inc (CDXS) - DWinneX
Global Biocatalysis Market Growth Trends & Insights2024-2031 - openPR.com
LPL Financial LLC Buys 35,335 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Metabolic Engineering Market Is Booming Worldwide 2025-2032 | Codexis, Inc.,Amyris, Inc.,Ginkgo Bioworks - openPR.com
Opaleye Management Makes a Bold Move with Major Codexis Stock Purchase - TipRanks
Codexis Inc [CDXS] 10% Owner makes an insider purchase of 100,000 shares worth 0.2 million. - knoxdaily.com
Codexis shares acquired by Opaleye Management total $298,772 - Investing.com Canada
Codexis shares acquired by Opaleye Management total $298,772 By Investing.com - Investing.com South Africa
Franklin Resources Inc. Increases Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World
Vanguard Group Inc. Purchases 311,082 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Major Investment Alert: Opaleye Management Inc. Boosts Stake in Codexis! - TipRanks
Codexis Announces Byron Dorgan to Retire from Board of Directors - GuruFocus
Codexis Announces Board Member Retirement in April 2025 - MSN
Veteran Chairman Byron Dorgan Exits Codexis Board: Key Details of Leadership Transition - Stock Titan
Codexis shares bought by Opaleye Management for $198,380 - Investing.com India
Is Now The Time To Buy Codexis Inc (NASDAQ: CDXS) Stock? - stocksregister.com
Codexis, Inc. (NASDAQ:CDXS) Shares Acquired by Commonwealth Equity Services LLC - Defense World
Codexis sees significant stock purchase by Opaleye Management, Inc. for $271,788 - Investing.com UK
Codexis stock hits 52-week low at $2.43 amid market challenges By Investing.com - Investing.com South Africa
Codexis stock hits 52-week low at $2.43 amid market challenges - Investing.com Australia
Protein Engineering Market Is Booming So Rapidly | Major Giants Merck KGaA, Agilent Technologies, Codexis - newstrail.com
5 "Best" Publicly Traded Synthetic Biology Companies - Securities.io
Codexis Appoints Cynthia Collins to Board of Directors - GlobeNewswire
RNA Pioneer and Former Editas CEO Joins Codexis Board: Strategic Move for RNA Therapeutics Push - Stock Titan
Codexis appoints new independent board member By Investing.com - Investing.com Canada
Charles Schwab Investment Management Inc. Purchases 26,052 Shares of Codexis, Inc. (NASDAQ:CDXS) - Defense World
Codexis appoints new independent board member - Investing.com India
Codexis, Inc. (NASDAQ:CDXS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing - simplywall.st
Codexis, Inc. (NASDAQ:CDXS) Holdings Increased by Bank of New York Mellon Corp - Defense World
Codexis sees $236,283 in stock purchases by Opaleye management - Investing.com Australia
Opaleye Management Inc. Expands Stake in Codexis Inc. - GuruFocus
Codexis Announces First Revenue-Generating Contract for ECO Synthesis™ Manufacturing Services - GlobeNewswire
New Contract Propels Codexis (CDXS) Stock Upward, Signaling Market Optimism - Stocks Telegraph
Codexis Signs First Contract for ECO Synthesis Manufacturing Services -March 24, 2025 at 08:17 am EDT - MarketScreener
Codexis Inc Stock (CDXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.04%
2.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):